The twice-yearly shot lenacapavir, sold under the name Yeztugo, reportedly nearly eliminated new HIV infections in studies of ...

The FDA has approved Lenacapavir a drug touted to be 999 effective in preventing HIV But it remains inaccessible for Indians ...

The FDA has approved Yeztugo for PrEP to reduce the risk of sexually acquired HIV-1 in adults and adolescents weighing at least 35kg.

While PrEP tablets are already prescribed around the world to prevent people from contracting HIV, experts in the US hope a newly approved jab could improve rates of protection.

Whereas the new HIV prevention drug, Lenacapavir, is a positive step towards HIV prevention, its cost is prohibitive. The ...

Gilead Sciences’ first quarter performance saw sales remain flat year over year, which did not meet Wall Street’s revenue expectations and prompted a negative market reaction. Management attributed ...

A recent study revealed that weed is linked with a doubled mortality risk from cardiac diseases. The study further discovered ...

The 'sitting-rising test' is a non-aerobic fitness assessment of the muscle strength, flexibility, balance, and body composition of an individual ...

India denies fake claims of US using its airspace for Iran strikes. PIB Fact Check confirms no Indian airspace was used in ...